Aquila Biotech Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2009.

2009 Mumbai, Maharashtra, India Active

Last Updated: February 13, 2026

About Aquila Biotech Private Limited

Aquila Biotech Private Limited, a active private limited company, was established on 17 July 2009 in Mumbai, Maharashtra, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U36935MH2009PTC194165. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a active non-compliant status. Its leadership includes Rajendra Chandrakant Potnis (Director), Franklin Charles Fernandes (Director). Past directors included Atul Digamber Khanolkar, Arti Atul Khanolkar, Girish Ravindra Amonker. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 15, Anuradha Society, Irla Bridge, Next To Fire Brigade Stn, S.V. Road Andh, Eri (West), Mumbai, Maharashtra, 400058.

Company Details

CIN/LLPIN
U36935MH2009PTC194165
Registration Number
194165
Incorporation Date
17 July 2009
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.50 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 13-02-2026
Paid Up Capital ₹ 0.50 M as on 13-02-2026
Company Age 16 Year, 7 Months
Last Filing with ROC 31 Mar 2020

Comprehensive Company Insights

Explore comprehensive insights into Aquila Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Aquila Biotech Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rajendra Chandrakant Potnis	Director	17 Jul 2009	Current
Franklin Charles Fernandes	Director	21 Apr 2014	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	07 Feb 2012	Past
Pramod Abcsdd	Director	22 Mar 2012	Past
Pramod Abcsdd	Director	15 May 2014	Past
Pramod Abcsdd	Director	25 Feb 2012	Past
Pramod Abcsdd	Director	02 Feb 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aquila Biotech.

Aquila Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aquila Biotech?

In 2017, Aquila Biotech had a promoter holding of 40.26% and a public holding of 59.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aquila Biotech?

Unlock and access historical data on people associated with Aquila Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aquila Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquila Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aquila Biotech

Recent Activity within the Organization

Annual General Meeting

Aquila Biotech Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
31 Dec 2020
Balance Sheet

Progress on Aquila Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was documented.
31 Mar 2020
Director Appointment

Progress on Franklin Charles Fernandes was appointed as a Director was appointed as a Director on 21 Apr 2014 & has been associated with this company since 11 years 9 months . was documented.
21 Apr 2014
Director Appointment

Rajendra Chandrakant Potnis was appointed as a Director was appointed as a Director on 17 Jul 2009 & has been associated with this company since 16 years 7 months . was recorded as a recent event.
17 Jul 2009
Company Incorporation

Aquila Biotech Private Limited was registered on 17 Jul 2009 with Roc Mumbai & aged 16 years 7 months as per MCA records. was recorded as a recent event.
17 Jul 2009

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Aquila Biotech Private Limited?

The CIN of Aquila Biotech Private Limited is U36935MH2009PTC194165.

Where is Aquila Biotech Private Limited headquartered?

Aquila Biotech Private Limited is headquartered at 15, Anuradha Society, Irla Bridge, Next To Fire Brigade Stn, S.V. Road Andh, Eri (West), Mumbai, Maharashtra, 400058.

When was Aquila Biotech Private Limited incorporated?

Aquila Biotech Private Limited was incorporated on 17 July 2009.

Who are the current directors of Aquila Biotech Private Limited?

The current directors of Aquila Biotech Private Limited are

What is the primary industry of Aquila Biotech Private Limited?

The primary industry of Aquila Biotech Private Limited is Manufacturing.

Is Aquila Biotech Private Limited a listed company?

Aquila Biotech Private Limited is unlisted.

What is the capital structure of Aquila Biotech Private Limited?

The authorized capital of Aquila Biotech Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Aquila Biotech Private Limited?

The compliance status of Aquila Biotech Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available